The Technical Advisory Group (TAG), an independent advisory panel of the World Health Organisation (WHO), has sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order to conduct a final Emergency Use Listing (EUL) risk-benefit assessment for global use of the vaccine.source https://timesofindia.indiatimes.com/india/bharat-biotech-submits-additional-data-to-who-decision-on-covaxin-likely-on-november-3/articleshow/87493963.cms
Comments
Post a Comment